We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLUE
3726
DELISTED
bluebird bio
BLUE
$45.3K ﹤0.01%
713
+50
+8% +$5.71K
SPCE icon
3727
Virgin Galactic
SPCE
$474M
$45.2K ﹤0.01%
558
-49
-8% -$4.88K
YALA
3728
Yalla Group
YALA
$821M
$44.9K ﹤0.01%
11,400
+299
+3% +$1.3K
COMP icon
3729
Compass
COMP
$10.2B
$44.8K ﹤0.01%
+13,870
New +$47.6K
VICI icon
3730
PUT
VICI Properties
VICI
$29B
$44K ﹤0.01%
+1,600
New +$52.9K
ORGN
3731
DELISTED
Origin Materials
ORGN
$43.1K ﹤0.01%
337
-6
-2% -$886
CVM icon
3732
CEL-SCI Corp
CVM
$26M
$42.7K ﹤0.01%
613
ESOA icon
3733
Energy Services of America
ESOA
$234M
$42.4K ﹤0.01%
18,497
TDAY
3734
USA Today Co
TDAY
$1B
$41.2K ﹤0.01%
22,044
-5,324
-19% -$12.5K
JVA icon
3735
Coffee Holding Co
JVA
$20.2M
$40.8K ﹤0.01%
21,800
-3,000
-12% -$6.34K
TSP
3736
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$39.5K ﹤0.01%
26,870
+5,094
+23% +$9.63K
DCFC
3737
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$39.5K ﹤0.01%
154
+2
+1% +$586
TSLA icon
3738
PUT
Tesla
TSLA
$1.34T
$39K ﹤0.01%
+200
New +$34.9K
TCRT icon
3739
Alaunos Therapeutics
TCRT
$4.88M
$38.6K ﹤0.01%
408
-36
-8% -$3.43K
ETON icon
3740
Eton Pharmaceutcials
ETON
$1.12B
$38.5K ﹤0.01%
+10,000
New +$36.5K
SLGC
3741
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$38.3K ﹤0.01%
15,000
+1,930
+15% +$5.53K
INVZ icon
3742
Innoviz Technologies
INVZ
$115M
$38.1K ﹤0.01%
+10,900
New +$48.3K
WRAP icon
3743
Wrap Technologies
WRAP
$98M
$38K ﹤0.01%
22,100
CMU
3744
DELISTED
MFS High Yield Municipal Trust
CMU
$36.6K ﹤0.01%
11,415
NVTA
3745
DELISTED
Invitae Corporation
NVTA
$36.6K ﹤0.01%
27,106
-2,564
-9% -$5.05K
FBIO icon
3746
Fortress Biotech
FBIO
$99M
$36.5K ﹤0.01%
2,965
QUOT
3747
DELISTED
Quotient Technology Inc
QUOT
$35.9K ﹤0.01%
10,953
CCO icon
3748
Clear Channel Outdoor Holdings
CCO
$1.19B
$35.9K ﹤0.01%
29,900
NUVB icon
3749
Nuvation Bio
NUVB
$2.14B
$35.9K ﹤0.01%
21,610
+600
+3% +$1.22K
ELTX icon
3750
Elicio Therapeutics
ELTX
$82.5M
$34.8K ﹤0.01%
6,000

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.